Clinical Trials Directory

Trials / Completed

CompletedNCT07257666

Sensory Deficit Following ACL Reconstruction: PRF Pilot Study

The Effect of Platelet-rich Fibrin on the Regeneration of Patellar Ligament Defects and the Functional Recovery of Patients After Anterior Cruciate Ligament Reconstruction of the Knee

Status
Completed
Phase
Study type
Observational
Enrollment
53 (actual)
Sponsor
University of Belgrade · Academic / Other
Sex
Male
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Pilot, single-center, non-randomized, parallel-group clinical study designed to assess whether intraoperative application of autologous platelet-rich fibrin (PRF) at the bone-patellar tendon-bone (BPTB) donor site reduces postoperative anterior knee sensory deficit after anterior cruciate ligament (ACL) reconstruction in competitively active male athletes. Planned enrollment is 53 participants allocated to a PRF cohort or a standard-care cohort. The primary outcome is the proportion of participants without anterior knee sensory deficit at 12 months post-surgery.

Detailed description

Background: Sensory deficit around the BPTB donor site is a recognized complication after ACL reconstruction and may affect patient satisfaction and functional recovery. PRF is an autologous bioregenerative product with potential to support soft-tissue healing. Objective: To determine whether PRF application at the donor site reduces anterior knee sensory deficit compared with standard surgical care. Design and Participants: Single-center, prospective, pilot, non-randomized study with two parallel cohorts (PRF vs standard care). Competitively active male athletes meeting prespecified eligibility criteria are followed at 4, 8, and 12 months post-surgery. Recruitment window: January 2022 to January 2023. Interventions: In the PRF cohort, PRF is prepared intraoperatively and applied to the donor site per manufacturer protocol; the comparator cohort receives standard closure without PRF. Assessments: Primary outcome: Proportion of participants without anterior knee sensory deficit at 12 months. Sensory testing is performed over a predefined 9-point area lateral to the surgical scar (eyes closed; contralateral knee used as reference if uncertain). Secondary outcomes: Patient-reported knee function instruments (International Knee Documentation Committee \[IKDC\] Subjective Knee Form and Lysholm Knee Scoring Scale), each reported as total score (0-100; higher scores indicate better function) at 4, 8, and 12 months; optional MRI-based assessments of the donor site per protocol; safety monitoring of adverse events. Analysis (planned): Group comparisons using appropriate categorical and non-parametric methods with prespecified approaches to handle multiplicity.

Conditions

Interventions

TypeNameDescription
BIOLOGICALPlatelet-rich fibrin (PRF)Autologous PRF prepared intraoperatively from patient's venous blood and applied at the donor site after graft harvesting.
PROCEDUREStandard Closure (Control)Conventional closure of the donor site without PRF application

Timeline

Start date
2022-01-07
Primary completion
2023-01-07
Completion
2025-07-14
First posted
2025-12-02
Last updated
2025-12-15

Locations

1 site across 1 country: Serbia

Source: ClinicalTrials.gov record NCT07257666. Inclusion in this directory is not an endorsement.